RELISEAL

Anesthetics

Description
Shipping Options
Customer Reviews

Definition: RELISEAL is a long-acting topical/local anaesthetic formulation, typically combining Lidocaine with advanced delivery agents (e.g., liposomal or polymer-based technology) for prolonged numbing effects.

INTRODUCTION

Used for extended-duration pain control, RELISEAL is ideal for:

Post-surgical wound care (e.g., burns, grafts).
Chronic pain management (neuropathy, shingles).
Procedural anaesthesia (lumbar punctures, long dermatologic procedures).

Unlike traditional anaesthetics, it provides 6–12 hours of analgesia per application.

DESCRIPTION

Active Ingredients:

Lidocaine (3–5%) – Rapid onset.
Adjuncts:
- Tetracaine (1–2%) – Extends duration.
- Liposomal encapsulation – Enhances skin penetration and delays absorption.

Formulations:

Cream/Gel – For intact skin.
Patches – For targeted, controlled release (e.g., post-herpetic neuralgia).
Injectable depot (under development) – For surgical site infiltration.

Pharmacokinetics:

Onset: 15–30 minutes (topical); faster if mucosa is treated.
Duration: 6–12 hours (vs. 1–2 hours for standard lidocaine).

USES

Surgical Aftercare:
- Reduces opioid needs post-operatively.
Chronic Conditions:
- Diabetic neuropathy, post-mastectomy pain.
Dermatology:
- Laser resurfacing, tattoo removal.
Pediatrics:
- Painless dressing changes for burns.

SIDE EFFECTS

Common:

Local erythema or edema (mild, resolves quickly).
Temporary numbness beyond treatment area.

Serious (Rare):

Contact dermatitis (with prolonged patch use).
Systemic toxicity (if applied to large broken skin areas):
- Blurred vision, arrhythmias.

IMPORTANCE

Reduces reliance on opioids for post-procedural pain.
Patient-friendly – Fewer reapplications needed.
Cost-effective for long-duration needs.

STORAGE

Refrigerate (2–8°C) if liposomal; room temp for others.
Avoid freezing or humidity.

CONCLUSION

RELISEAL bridges the gap between short-acting locals and systemic analgesics, offering safer, sustained relief. Ideal for outpatient procedures and chronic pain, but requires monitoring for skin reactions.

Contraindications:

Open wounds (unless formulated for mucosa).
History of local anaesthetic allergy.

Definition:
RELISEAL is a long-acting topical/local anaesthetic formulation, typically combining Lidocaine with advanced delivery agents (e.g., liposomal or polymer-based technology) for prolonged numbing effects.

INTRODUCTION

Used for extended-duration pain control, RELISEAL is ideal for:

Post-surgical wound care (e.g., burns, grafts).
Chronic pain management (neuropathy, shingles).
Procedural anaesthesia (lumbar punctures, long dermatologic procedures).

Unlike traditional anaesthetics, it provides 6–12 hours of analgesia per application.

DESCRIPTION

Active Ingredients:

Lidocaine (3–5%) – Rapid onset.
Adjuncts:
- Tetracaine (1–2%) – Extends duration.
- Liposomal encapsulation – Enhances skin penetration and delays absorption.

Formulations:

Cream/Gel – For intact skin.
Patches – For targeted, controlled release (e.g., post-herpetic neuralgia).
Injectable depot (under development) – For surgical site infiltration.

Pharmacokinetics:

Onset: 15–30 minutes (topical); faster if mucosa is treated.
Duration: 6–12 hours (vs. 1–2 hours for standard lidocaine).

USES

Surgical Aftercare:
- Reduces opioid needs post-operatively.
Chronic Conditions:
- Diabetic neuropathy, post-mastectomy pain.
Dermatology:
- Laser resurfacing, tattoo removal.
Pediatrics:
- Painless dressing changes for burns.

SIDE EFFECTS

Common:

Local erythema or edema (mild, resolves quickly).
Temporary numbness beyond treatment area.

Serious (Rare):

Contact dermatitis (with prolonged patch use).
Systemic toxicity (if applied to large broken skin areas):
- Blurred vision, arrhythmias.

IMPORTANCE

Reduces reliance on opioids for post-procedural pain.
Patient-friendly – Fewer reapplications needed.
Cost-effective for long-duration needs.

STORAGE

Refrigerate (2–8°C) if liposomal; room temp for others.
Avoid freezing or humidity.

CONCLUSION

Contraindications:

Open wounds (unless formulated for mucosa).
History of local anaesthetic allergy.

Shipping Options –

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions –

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Description
Reviews (0)

Definition:
RELISEAL is a long-acting topical/local anaesthetic formulation, typically combining Lidocaine with advanced delivery agents (e.g., liposomal or polymer-based technology) for prolonged numbing effects.

INTRODUCTION

Used for extended-duration pain control, RELISEAL is ideal for:

Post-surgical wound care (e.g., burns, grafts).
Chronic pain management (neuropathy, shingles).
Procedural anaesthesia (lumbar punctures, long dermatologic procedures).

Unlike traditional anaesthetics, it provides 6–12 hours of analgesia per application.

DESCRIPTION

Active Ingredients:

Lidocaine (3–5%) – Rapid onset.
Adjuncts:
- Tetracaine (1–2%) – Extends duration.
- Liposomal encapsulation – Enhances skin penetration and delays absorption.

Formulations:

Cream/Gel – For intact skin.
Patches – For targeted, controlled release (e.g., post-herpetic neuralgia).
Injectable depot (under development) – For surgical site infiltration.

Pharmacokinetics:

Onset: 15–30 minutes (topical); faster if mucosa is treated.
Duration: 6–12 hours (vs. 1–2 hours for standard lidocaine).

USES

Surgical Aftercare:
- Reduces opioid needs post-operatively.
Chronic Conditions:
- Diabetic neuropathy, post-mastectomy pain.
Dermatology:
- Laser resurfacing, tattoo removal.
Pediatrics:
- Painless dressing changes for burns.

SIDE EFFECTS

Common:

Local erythema or edema (mild, resolves quickly).
Temporary numbness beyond treatment area.

Serious (Rare):

Contact dermatitis (with prolonged patch use).
Systemic toxicity (if applied to large broken skin areas):
- Blurred vision, arrhythmias.

IMPORTANCE

Reduces reliance on opioids for post-procedural pain.
Patient-friendly – Fewer reapplications needed.
Cost-effective for long-duration needs.

STORAGE

Refrigerate (2–8°C) if liposomal; room temp for others.
Avoid freezing or humidity.

CONCLUSION

Contraindications:

Open wounds (unless formulated for mucosa).
History of local anaesthetic allergy.

Reviews

There are no reviews yet.

Be the first to review “RELISEAL”

Description
Reviews (0)

Definition:
RELISEAL is a long-acting topical/local anaesthetic formulation, typically combining Lidocaine with advanced delivery agents (e.g., liposomal or polymer-based technology) for prolonged numbing effects.

INTRODUCTION

Used for extended-duration pain control, RELISEAL is ideal for:

Post-surgical wound care (e.g., burns, grafts).
Chronic pain management (neuropathy, shingles).
Procedural anaesthesia (lumbar punctures, long dermatologic procedures).

Unlike traditional anaesthetics, it provides 6–12 hours of analgesia per application.

DESCRIPTION

Active Ingredients:

Lidocaine (3–5%) – Rapid onset.
Adjuncts:
- Tetracaine (1–2%) – Extends duration.
- Liposomal encapsulation – Enhances skin penetration and delays absorption.

Formulations:

Cream/Gel – For intact skin.
Patches – For targeted, controlled release (e.g., post-herpetic neuralgia).
Injectable depot (under development) – For surgical site infiltration.

Pharmacokinetics:

Onset: 15–30 minutes (topical); faster if mucosa is treated.
Duration: 6–12 hours (vs. 1–2 hours for standard lidocaine).

USES

Surgical Aftercare:
- Reduces opioid needs post-operatively.
Chronic Conditions:
- Diabetic neuropathy, post-mastectomy pain.
Dermatology:
- Laser resurfacing, tattoo removal.
Pediatrics:
- Painless dressing changes for burns.

SIDE EFFECTS

Common:

Local erythema or edema (mild, resolves quickly).
Temporary numbness beyond treatment area.

Serious (Rare):

Contact dermatitis (with prolonged patch use).
Systemic toxicity (if applied to large broken skin areas):
- Blurred vision, arrhythmias.

IMPORTANCE

Reduces reliance on opioids for post-procedural pain.
Patient-friendly – Fewer reapplications needed.
Cost-effective for long-duration needs.

STORAGE

Refrigerate (2–8°C) if liposomal; room temp for others.
Avoid freezing or humidity.

CONCLUSION

Contraindications:

Open wounds (unless formulated for mucosa).
History of local anaesthetic allergy.

Reviews

There are no reviews yet.

Be the first to review “RELISEAL”

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.